MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Phosphodiesterase Type-4 inhibitors

Drug Safety Update

 January 2017: Apremilast (Otezla ▼): risk of suicidal thoughts and behaviour

NICE Guidance (See also drug specific guidance below)

NG100: Rheumatoid arthritis in adults: management, July 2018 (updated October 2020)

Blue-teq funding form to be completed

Pack Price
4 tablet
Pack Price
4 tablet
Pack Price
19 tablet
56 tablet (4 x 14 tablets) £550.00